DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.27 +0.07 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026)

Updated

DiaMedica Therapeutics' Operating Leases was $69,000 in Q2 2026, down 60.8% from $176,000 a year earlier and down 28.1% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at DiaMedica Therapeutics came in at $124,000, down 44.9% from FY2024.

  • Operating Leases has now declined for three consecutive years, though with a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
  • In earlier years, Operating Leases was $225,000 in FY2024 (-28.8%), $316,000 in FY2023 (-20.2%), $396,000 in FY2022 and $3,000 in FY2021 (-93.5%).
  • The Q2 2026 figure marks the lowest quarterly Operating Leases since Q2 2023.
  • Compared with a year earlier, Operating Leases has declined for eight straight quarters, with an average decline of 39.9% over the last eight quarters.
  • Across the past five years, year-over-year decline in Operating Leases ran from 18.8% in Q3 2023 to 93.5% in Q4 2021.
  • Per Business Quant data, DMAC's Operating Leases in the three quarters before Q2 2026 was $96,000 (Q1 2026), $124,000 (Q4 2025) and $150,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69,000.00
Mar 31, 2026 96,000.00
Dec 31, 2025 124,000.00
Sep 30, 2025 150,000.00
Jun 30, 2025 176,000.00
Mar 31, 2025 201,000.00
Dec 31, 2024 225,000.00
Sep 30, 2024 249,000.00
Jun 30, 2024 272,000.00
Mar 31, 2024 294,000.00
Dec 31, 2023 316,000.00
Sep 30, 2023 337,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 4,000.00
Dec 31, 2022 396,000.00
Sep 30, 2022 415,000.00
Dec 31, 2021 3,000.00
Jun 30, 2021 11,000.00
Mar 31, 2021 28,000.00
Dec 31, 2020 46,000.00
API Access

DiaMedica Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=DMAC&period=max&api_key=YOUR_API_KEY